Session

Molecular avatars in gastrointestinal carcinogenesis (Posters)

LIPOPOLYSACCHARIDE DIFFERENTLY MODULATES MICRORNA PROFILES IN BOTH COLON EPITHELIAL CELLS AND THEIR EXTRACELLULAR VESICLES
LIPOPOLYSACCHARIDE DIFFERENTLY MODULATES MICRORNA PROFILES IN BOTH COLON EPITHELIAL CELLS AND THEIR EXTRACELLULAR VESICLES

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

GASTRIC CANCER DEVELOPMENT MECHANISM FROM INTESTINAL METAPLASIA USING METABOLOMIC PROFILING
GASTRIC CANCER DEVELOPMENT MECHANISM FROM INTESTINAL METAPLASIA USING METABOLOMIC PROFILING

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

ENDOSCOPIC SURVEILLANCE IN PATIENTS WITH PATHOGENIC VARIANTS IN CDH1 OR CTNNA1 – A REAL WORLD SCENARIO
ENDOSCOPIC SURVEILLANCE IN PATIENTS WITH PATHOGENIC VARIANTS IN CDH1 OR CTNNA1 – A REAL WORLD SCENARIO

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

ABERRANT P53 EXPRESSION IS THE STRONGEST PREDICTOR FOR NEOPLASTIC PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS
ABERRANT P53 EXPRESSION IS THE STRONGEST PREDICTOR FOR NEOPLASTIC PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

INCREASING SIMILARITY OF MICROBIOTA COMPOSITIONS AMONG SALIVA, GASTRIC JUICE, AND GASTRIC TISSUE SAMPLES DURING GASTRIC CARCINOGENESIS
INCREASING SIMILARITY OF MICROBIOTA COMPOSITIONS AMONG SALIVA, GASTRIC JUICE, AND GASTRIC TISSUE SAMPLES DURING GASTRIC CARCINOGENESIS

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

SLC26A9 PROTECTS THE MUCOAL DEFENSE BARRIER AGAINST PHG BY ATTENUATING ER STRESS MEDIATED MITOCHONDRIA-DEPENDENT APOPTOTIC SIGNALING
SLC26A9 PROTECTS THE MUCOAL DEFENSE BARRIER AGAINST PHG BY ATTENUATING ER STRESS MEDIATED MITOCHONDRIA-DEPENDENT APOPTOTIC SIGNALING

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

UPDATED PREVALENCE AND CLINICOPATHOLOGICAL FEATURES OF OXYNTIC GLAND NEOPLASIA
UPDATED PREVALENCE AND CLINICOPATHOLOGICAL FEATURES OF OXYNTIC GLAND NEOPLASIA

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

REVISITING THE ARACHIDONIC ACID PATHWAY IN GASTRIC CANCER: A TRANCRIPTOMICS APPROACH TOWARDS THE DISCOVERY OF NOVEL BIOMARKERS
REVISITING THE ARACHIDONIC ACID PATHWAY IN GASTRIC CANCER: A TRANCRIPTOMICS APPROACH TOWARDS THE DISCOVERY OF NOVEL BIOMARKERS

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

INFLUENCE OF CULTURE MEDIA COMPOSITION ON WNT/Β-CATENIN SIGNALING IN APC-MUTATED INTESTINAL ORGANOIDS
INFLUENCE OF CULTURE MEDIA COMPOSITION ON WNT/Β-CATENIN SIGNALING IN APC-MUTATED INTESTINAL ORGANOIDS

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

ACTIVATION OF NECROPTOSIS AS AN APPROACH TO OVERCOME DRUG RESISTANCE IN CANCER CELLS
ACTIVATION OF NECROPTOSIS AS AN APPROACH TO OVERCOME DRUG RESISTANCE IN CANCER CELLS

Molecular avatars in gastrointestinal carcinogenesis (Posters)  et al.

LIPOPOLYSACCHARIDE DIFFERENTLY MODULATES MICRORNA PROFILES IN BOTH COLON EPITHELIAL CELLS AND THEIR EXTRACELLULAR VESICLES
LIPOPOLYSACCHARIDE DIFFERENTLY MODULATES MICRORNA PROFILES IN BOTH COLON EPITHELIAL CELLS AND THEIR EXTRACELLULAR VESICLES

GASTRIC CANCER DEVELOPMENT MECHANISM FROM INTESTINAL METAPLASIA USING METABOLOMIC PROFILING
GASTRIC CANCER DEVELOPMENT MECHANISM FROM INTESTINAL METAPLASIA USING METABOLOMIC PROFILING

INCREASING SIMILARITY OF MICROBIOTA COMPOSITIONS AMONG SALIVA, GASTRIC JUICE, AND GASTRIC TISSUE SAMPLES DURING GASTRIC CARCINOGENESIS
INCREASING SIMILARITY OF MICROBIOTA COMPOSITIONS AMONG SALIVA, GASTRIC JUICE, AND GASTRIC TISSUE SAMPLES DURING GASTRIC CARCINOGENESIS

SLC26A9 PROTECTS THE MUCOAL DEFENSE BARRIER AGAINST PHG BY ATTENUATING ER STRESS MEDIATED MITOCHONDRIA-DEPENDENT APOPTOTIC SIGNALING
SLC26A9 PROTECTS THE MUCOAL DEFENSE BARRIER AGAINST PHG BY ATTENUATING ER STRESS MEDIATED MITOCHONDRIA-DEPENDENT APOPTOTIC SIGNALING

UPDATED PREVALENCE AND CLINICOPATHOLOGICAL FEATURES OF OXYNTIC GLAND NEOPLASIA
UPDATED PREVALENCE AND CLINICOPATHOLOGICAL FEATURES OF OXYNTIC GLAND NEOPLASIA

REVISITING THE ARACHIDONIC ACID PATHWAY IN GASTRIC CANCER: A TRANCRIPTOMICS APPROACH TOWARDS THE DISCOVERY OF NOVEL BIOMARKERS
REVISITING THE ARACHIDONIC ACID PATHWAY IN GASTRIC CANCER: A TRANCRIPTOMICS APPROACH TOWARDS THE DISCOVERY OF NOVEL BIOMARKERS

INFLUENCE OF CULTURE MEDIA COMPOSITION ON WNT/Β-CATENIN SIGNALING IN APC-MUTATED INTESTINAL ORGANOIDS
INFLUENCE OF CULTURE MEDIA COMPOSITION ON WNT/Β-CATENIN SIGNALING IN APC-MUTATED INTESTINAL ORGANOIDS

ACTIVATION OF NECROPTOSIS AS AN APPROACH TO OVERCOME DRUG RESISTANCE IN CANCER CELLS
ACTIVATION OF NECROPTOSIS AS AN APPROACH TO OVERCOME DRUG RESISTANCE IN CANCER CELLS

ENDOSCOPIC SURVEILLANCE IN PATIENTS WITH PATHOGENIC VARIANTS IN CDH1 OR CTNNA1 – A REAL WORLD SCENARIO
ENDOSCOPIC SURVEILLANCE IN PATIENTS WITH PATHOGENIC VARIANTS IN CDH1 OR CTNNA1 – A REAL WORLD SCENARIO

ABERRANT P53 EXPRESSION IS THE STRONGEST PREDICTOR FOR NEOPLASTIC PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS
ABERRANT P53 EXPRESSION IS THE STRONGEST PREDICTOR FOR NEOPLASTIC PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS

Item 1 - 20 / 20
1